Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia

Molecular Psychiatry

Volumn 5, Issue 5, 2000, Pages 558-562

  Krebs, M O ^a   Guillin, O ^a,b   Bourdel, M C ^a   Schwartz, J C ^b   Olie, J P ^a   Poirier, M F ^a   Sokoloff, P ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

Association study; Dopamine D3 receptor; Drug abuse; Neurodevelopment; Neurotrophin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 3 RECEPTOR; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DNA POLYMORPHISM; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 0033808601     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000749     Document Type: Article

References (30)

1. A neurohistological correlate of schizophrenia
2. Cortical maldevelopment, anti-psychotic drugs and schizophrenia: A search for common ground
3. Minor physical anomalies in alcoholic and schizophrenic adults and hyperactive and autistic children
4. Brain morphology in first episode schizophrenic-like psychotic patients: A quantitative magnetic resonance imaging study
5. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
6. Neurotrophins and neuronal plasticity
7. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo
8. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via the Trk and p75Lntr receptors
9. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophin factor and neurotrophin-3 mRNAs
10. Anterograde transport of brain-derived neurotrophic factor and its role in the brain
11. Effect of chlorpromazine or haloperidol on the formation of 3-methoxytyramine and normetanephrine in mouse brain
12. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
13. 3 receptor expression
14. Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF)
15. Dopamine D3 receptor gene variants and substance abuse in schizophrenia
16. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families
17. Brain-derived neurotrophic factor gene and schizophrenia in Japanese subjects
18. Gender and age at onset in schizophrenia: Impact of family history
19. Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal
20. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia
21. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients
22. 3 receptors and use of antipsychotics in patients with schizophrenia
23. 3) as a target for neuroleptics
24. Dissecting the genetic complexity of schizophrenia
25. A diagnostic interview: A schedule for affective disorders and schizophrenia
26. The positive and negative symptom scale (PANSS)
27. Onset and early course of schizophrenia
28. Age at onset in subtypes of schizophrenic disorders
29. A systematic approach to treatment resistance in schizophrenic disorders